0001104659-19-042123.txt : 20190726
0001104659-19-042123.hdr.sgml : 20190726
20190726213016
ACCESSION NUMBER: 0001104659-19-042123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOODGRIFT RANDEL WILLIAM
CENTRAL INDEX KEY: 0001204554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 19979217
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
a4.xml
4
X0306
4
2019-07-24
0
0000001800
ABBOTT LABORATORIES
ABT
0001204554
WOODGRIFT RANDEL WILLIAM
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
0
1
0
0
Senior Vice President
Common shares without par value
2019-07-24
4
M
0
65000
38.40
A
117562
D
Common shares without par value
2019-07-24
4
S
0
65000
88.0050
D
52562
D
Common shares without par value
2755
I
Profit Sharing Trust
Option (right to buy)
38.40
2019-07-24
4
M
0
65000
0
D
2019-02-19
2026-02-18
Common shares
65000
18333
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Balance in the Abbott Laboratories Stock Retirement Trust as of July 24, 2019.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Jessica H. Paik, by power of attorney for Randel W. Woodgrift
2019-07-26